Literature DB >> 35895273

Analysis of Oligonucleotide Biodistribution and Metabolization in Experimental Animals.

François Halloy1,2, Paulina Brönnimann1,3, Jonathan Hall1, Daniel Schümperli4.   

Abstract

We describe methods to follow the fate of oligonucleotides after their injection into experimental animals. The quantitation in various tissues, blood or bone marrow cells is possible by chemical ligation PCR. This method works independently of chemical modifications of the oligonucleotide and/or its conjugations to lipid or peptide moieties. Moreover, metabolization intermediates can be detected by mass spectrometry. Together with a readout assay for the biochemical or physiological effects, which will differ, depending on the particular purpose of the oligonucleotide, these methods allow for a comprehensive understanding of oligonucleotide behavior in a living organism.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Chemical ligation qPCR; Mass spectrometry; Oligonucleotide biodistribution; Oligonucleotide conjugates; Oligonucleotide therapeutics

Mesh:

Substances:

Year:  2022        PMID: 35895273     DOI: 10.1007/978-1-0716-2521-7_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

1.  Tissue disposition of 2'-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeys.

Authors:  Rosie Z Yu; Richard S Geary; David K Monteith; John Matson; Loanne Truong; Jon Fitchett; Arthur A Levin
Journal:  J Pharm Sci       Date:  2004-01       Impact factor: 3.534

Review 2.  Treating Disease at the RNA Level with Oligonucleotides.

Authors:  Arthur A Levin
Journal:  N Engl J Med       Date:  2019-01-03       Impact factor: 91.245

Review 3.  RNA-Targeted Therapeutics.

Authors:  Stanley T Crooke; Joseph L Witztum; C Frank Bennett; Brenda F Baker
Journal:  Cell Metab       Date:  2018-04-03       Impact factor: 27.287

4.  LC-MS quantification of oligonucleotides in biological matrices with SPE or hybridization extraction.

Authors:  Luc Sips; Emmanuel Njumbe Ediage; Benno Ingelse; Tom Verhaeghe; Lieve Dillen
Journal:  Bioanalysis       Date:  2019-11       Impact factor: 2.681

Review 5.  FDA-Approved Oligonucleotide Therapies in 2017.

Authors:  Cy A Stein; Daniela Castanotto
Journal:  Mol Ther       Date:  2017-03-31       Impact factor: 11.454

Review 6.  Cellular uptake and trafficking of antisense oligonucleotides.

Authors:  Stanley T Crooke; Shiyu Wang; Timothy A Vickers; Wen Shen; Xue-Hai Liang
Journal:  Nat Biotechnol       Date:  2017-02-27       Impact factor: 54.908

7.  Quantitation of locked nucleic acid antisense oligonucleotides in mouse tissue using a liquid-liquid extraction LC-MS/MS analytical approach.

Authors:  Paul Turnpenny; Jaiessh Rawal; Torsten Schardt; Sandro Lamoratta; Heiko Mueller; Markus Weber; Kevin Brady
Journal:  Bioanalysis       Date:  2011-09       Impact factor: 2.681

8.  Metabolite Profiling of the Antisense Oligonucleotide Eluforsen Using Liquid Chromatography-Mass Spectrometry.

Authors:  Jaeah Kim; Babak Basiri; Chopie Hassan; Carine Punt; Erik van der Hage; Cathaline den Besten; Michael G Bartlett
Journal:  Mol Ther Nucleic Acids       Date:  2019-07-22       Impact factor: 8.886

9.  Delivery of oligonucleotides to bone marrow to modulate ferrochelatase splicing in a mouse model of erythropoietic protoporphyria.

Authors:  François Halloy; Pavithra S Iyer; Paulina Ćwiek; Alice Ghidini; Jasmin Barman-Aksözen; Nicole Wildner-Verhey van Wijk; Alexandre P A Theocharides; Elisabeth I Minder; Xiaoye Schneider-Yin; Daniel Schümperli; Jonathan Hall
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

10.  Whole-body scanning PCR; a highly sensitive method to study the biodistribution of mRNAs, noncoding RNAs and therapeutic oligonucleotides.

Authors:  Julien A Boos; David W Kirk; Mari-Luz Piccolotto; Werner Zuercher; Sandro Gfeller; Philippe Neuner; Andre Dattler; William L Wishart; Fabian Von Arx; Michael Beverly; Jesper Christensen; Karine Litherland; Esther van de Kerkhof; Pieter J Swart; Thomas Faller; Armin Beyerbach; David Morrissey; Juerg Hunziker; Iwan Beuvink
Journal:  Nucleic Acids Res       Date:  2013-06-13       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.